source
- Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shapeIt seems there’s room for two in the MASH market. When Novo Nordisk’s blockbuster weight loss drug Wegovy won approval in August 2025 to treat the fatty liver disease, some investors thought it wou…Endpoints · 3mo ago↗ source
- STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some formsLast year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says approval should be considered.STAT · 3mo ago↗ source
- STAT+: Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer's drugs.STAT · 3mo ago↗ source